LOGO
LOGO

Quick Facts

R.R. Donnelley & Sons Q1 Profit Decreases - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

R.R. Donnelley & Sons Company (RRD) reported that its first-quarter net income attributable to shareholders decreased to $27.1 million or $0.15 per share, from $37.4 million or $0.21 per share last year. First-quarter 2013 net income to shareholders included $62.5 million in pre-tax charges for restructuring, impairment, acquisition-related expenses, a loss on currency devaluation in Venezuela and a loss on debt extinguishment. Adjusted net earnings attributable to shareholders totaled $68.1 million or $0.37 per share, compared to $78.8 million or $0.44 per share prior year.

Net sales were $2.5 billion, an increase of 0.5% from the first quarter of 2012. Organic sales declined 1.2% from last year due to price erosion and volume declines in the U.S. Print and Related Services segment.

On average, four analysts polled by Thomson Reuters expected the company to report profit of $0.33 per share for the quarter. Analysts' estimates typically exclude special items. Analysts expected revenue of $2.46 billion for the quarter.

The company also announced that it continues to expect fiscal 2013 revenue in the range of $10.1 billion to $10.3 billion. Analysts expect the company to report fiscal 2013 revenue of $10.09 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19